Rosenberg Matthew Hamilton Astrazeneca PLC Transaction History
Rosenberg Matthew Hamilton
- $378 Million
- Q3 2024
A detailed history of Rosenberg Matthew Hamilton transactions in Astrazeneca PLC stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 1,540 shares of AZN stock, worth $109,986. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,540
Previous 1,540
-0.0%
Holding current value
$109,986
Previous $120,000
0.83%
% of portfolio
0.03%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,345Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.64 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.04 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.9 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.62 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.26 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...